Regulatory News
Friday, January 27, 2017
BRIEF-Aurinia selects Worldwide Clinical Trials as its CRO for Phase 3 lupus nephritis trial
* Aurinia selects Worldwide Clinical Trials as its CRO for
Phase 3 lupus nephritis trial
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment